Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bundamedik Tbk (BMHS) vs Chandra Asri Pacific Tbk. (TPIA) Price & Performance

Bundamedik TbkTrade
Chandra Asri Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Bundamedik Tbk vs Chandra Asri Pacific Tbk. — how do they compare? Bundamedik Tbk trades at Rp177 (market cap 1.51T, 42.1K 24h volume), while Chandra Asri Pacific Tbk. trades at Rp1,895 (market cap 165.24T, 79.55M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 109.4× Bundamedik Tbk's market cap, and Chandra Asri Pacific Tbk. is more actively traded (79.55M versus 42.1K). Which is the better fit depends on your goals.

BMHSTPIA
Market Cap
1.51T165.24T
Volume
42.1K79.55M
Lot
421795.53K
Turnover
7.44M151.56B
Average Price
176.711,905.1
Value
7.44M151.56B
Indicative Equilibrium Price
1771,925
Indicative Equilibrium Volume
1089.02K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMHS
View details
TPIA
View details

About Bundamedik Tbk

PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.

Read more on BMHS

About Chandra Asri Pacific Tbk.

PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.

Read more on TPIA